LifeSciences BC > News > Member Announcements > Page 2

Xenon Pharmaceuticals Provides Corporate Update in the Context of COVID-19

March 31, 2020
Xenon Pharmaceuticals Inc.

BURNABY, British Columbia, March 31, 2020 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today provided a corporate update in the context of the developing situation with the COVID-19 pandemic. Dr. Simon Pimstone, Xenon’s Chief Executive Officer, said, “The safety of Xenon’s employees and their families, as well as the healthcare … Continue reading Xenon Pharmaceuticals Provides Corporate Update in the Context of COVID-19

Curiox Biosystems and STEMCELL Technologies Announce Method to Safely Prepare COVID-19 Blood Samples for Vaccine Research

March 30, 2020
STEMCELL Technologies Inc.

Woburn, MA, March 30, 2020 – Curiox Biosystems in conjunction with STEMCELL Technologies today announced a new system that will help researchers develop vaccines to SARS-CoV-2, the virus that causes COVID-19. A new configuration of the Laminar Wash™ HT1000 System will allow scientists to completely process blood samples from COVID-19 positive patients in a safe … Continue reading Curiox Biosystems and STEMCELL Technologies Announce Method to Safely Prepare COVID-19 Blood Samples for Vaccine Research

CALL TO ACTION – COVID 19 ALL BC MEDICAL SUPPLIERS AND LABORATORIES

March 27, 2020
LifeSciences BC

March 27, 2020 – Vancouver, B.C. – As COVID 19 places a strain on urgent patient care and therapeutic treatments, a critical need has developed for medical supplies that are indispensable on the front line. To address this crucial need, LifeSciences BC has taken on the role of identifying, creating and collecting medical equipment to … Continue reading CALL TO ACTION – COVID 19 ALL BC MEDICAL SUPPLIERS AND LABORATORIES

Bold Therapeutics Seeks Collaborators for Rapid Development of BOLD-100; Lead Drug Candidate Has Potential Utility in the Treatment of COVID-19

March 27, 2020
Bold Therapeutics Inc.

Vancouver, BC – March 27, 2020 – Bold Therapeutics, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that recent developments have suggested the potential utility of its lead drug BOLD-100 as a novel antiviral agent. BOLD-100’s main mechanism of action is to inhibit stress-induced upregulation of GRP78. GRP78 is a common receptor for viral … Continue reading Bold Therapeutics Seeks Collaborators for Rapid Development of BOLD-100; Lead Drug Candidate Has Potential Utility in the Treatment of COVID-19

Genome BC Launches Rapid Response Funding for COVID-19 Projects

March 26, 2020
Genome BC

March 26, 2022 – Vancouver, Canada — Genome BC is today launching a rapid response funding program to invest in promising research and innovation projects with the real potential to address urgent challenges related to the COVID-19 pandemic.   The initiative is using a specifically designed process for reviewing applications and providing funds for approved … Continue reading Genome BC Launches Rapid Response Funding for COVID-19 Projects

adMare and BELLUS Health Close Transaction for Intellectual Property Rights to P2X3 Platform

March 26, 2020
adMare BioInnovations

Montréal, QC – March 26, 2020: As announced Wednesday by BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU) (the “Company” or “BELLUS”), adMare BioInnovations (“adMare”) and BELLUS have closed an agreement under which BELLUS has acquired full ownership of intellectual property previously licensed from adMare. adMare originally entered into a worldwide license agreement with BELLUS for … Continue reading adMare and BELLUS Health Close Transaction for Intellectual Property Rights to P2X3 Platform

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 26, 2020
XENON PHARMACEUTICALS INC.

BURNABY, British Columbia, March 26, 2020 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced equity inducement grants to eight new non-officer employees consisting of an aggregate of 63,200 share options. All of the foregoing share options were approved by the Compensation Committee of the Company’s Board of Directors with … Continue reading Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DelMar Pharmaceuticals Receives Nasdaq Bid Price Extension

March 26, 2020
DelMar Pharmaceuticals Inc.

SAN DIEGO, March 26, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, announced that it has received a listing extension from the Staff of the Listing Qualifications Department of The Nasdaq Capital Market LLC (Nasdaq).  The extension grants the Company until … Continue reading DelMar Pharmaceuticals Receives Nasdaq Bid Price Extension

Canadian Biotechnology Company STEMCELL Technologies Provides Critical Support to Sequence the COVID-19 Virus, Accelerating Vaccine Development

March 25, 2020
STEMCELL Technologies

Vancouver Canada, March 24, 2020 – Canada’s largest biotechnology company, Vancouver’s STEMCELL Technologies, has been making significant contributions to the fight against COVID-19. Human tissue culture systems developed by STEMCELL were used by researchers at China’s Centre for Disease Control (CDC) to grow lung airway cells that could successfully propagate the novel coronavirus SARS-CoV-2. Scientists … Continue reading Canadian Biotechnology Company STEMCELL Technologies Provides Critical Support to Sequence the COVID-19 Virus, Accelerating Vaccine Development

COVID 19 RESOURCES AND SUPPORT FOR CANADIAN BUSINESSES

March 22, 2020
Government of Canada

Disclaimer: This document is subject to change and does not necessarily represent official, current or finalized information. Resources for Suppliers Public Services and Procurement Canada (PSPC) Calling all suppliers – Help Canada combat Coronavirus disease (COVID-19) In support of the Government of Canada’s whole-of-government response to Coronavirus disease (COVID-19), PSPC is asking suppliers about their ability … Continue reading COVID 19 RESOURCES AND SUPPORT FOR CANADIAN BUSINESSES